The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

CORT FINANCIAL STATEMENTS

Corcept Therapeutics Incorporated — balance sheet, income statement and cash flow trends

CORTCorcept Therapeutics Incorporated

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
0250 M500 M750 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue830.8 M $Gross Profit816.7 M $ · 98%Operating Income6.4 M $ · 1%Pre-tax Income26.4 M $ · 3%Net Income to Owners54.9 M $ · 7%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue830.8 M $+16.0%
Gross Profit816.7 M $+15.9%
Operating Income6.4 M $-93.7%
EBITDA28.8 M $-77.5%
Net Income to Owners54.9 M $-58.7%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0250 M500 M750 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets888.7 M
  • Equity705.8 M $79%
  • Current Liabilities153.8 M $17%
  • Long-term Liabilities29.1 M $3%

Key Figures

YoY change
Total Assets888.7 M $+10.8%
Total Liabilities182.9 M $+10.2%
Total Equity705.8 M $+11.0%
Cash & ST Investments308.2 M $-9.9%
Total Debt9.4 M $+42.6%
Net Debt-101.6 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
0100 M200 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
050 M100 M109.7 M $Operating-21.9 M $Investing-78.9 M $Financing8.9 M $Net Change

Key Figures

YoY change
Operating Cash Flow109.7 M $-39.8%
Capital Expenditures2.8 M $+45.0%
Free Cash Flow106.9 M $-40.7%
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on CORT

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 2, 26. This content is for informational purposes only and is not investment advice.